 Hypothesis: In experimental inflammatory and human autoimmune diseases, such as Rheumatoid arthritis and related conditions 17, 19, and also in animal models in which Experimental Autoimmune Encephalitis EAE is induced, we have recently shown that Andrographolide can significantly reduce the clinical symptoms and outcome of this diseases 6, for which we have now proposed this clinical study in RRMS. 